DHPP vaccine for dogs

Canine Distemper, Parainfluenza, Hepatitis and Parvovirus Vaccine, Live

DHPP vaccine for dogs is an important vaccine for the prevention of four major canine diseases: distemper, parainfluenza, adenovirus and microvirus. This live vaccine contains attenuated strains of each virus to ensure effective protection for dogs. It is designed for weaned puppies and adult dogs and provides immunity for 12 months.

  • Vaccine Type: Live Attenuated (Modified Live Vaccine)
  • Target Species: Dogs
  • Indication / Application: Canine Distemper/Canine Parainfluenza/Canine Adenovirus Infection/Canine Parvovirus
  • Manufacturing: Produced in GMP-certified facility
  • Supply Mode: Bulk Supply / Distributor / OEM Available
  • Origin: China

Canine DHPP Vaccine (Live) Description

This live attenuated combination vaccine is designed to provide broad protection against four major infectious diseases affecting dogs: canine distemper virus (CDV), canine parainfluenza virus (CPIV), canine adenovirus (CAV), and canine parvovirus (CPV).

These diseases are highly contagious and widely distributed, particularly in high-density environments such as breeding kennels, shelters, and pet hospitals. Canine distemper and parvovirus are associated with high morbidity and mortality, especially in puppies, while adenovirus and parainfluenza contribute significantly to canine respiratory disease complex.

The vaccine contains carefully selected attenuated strains (CDV/R-20/8, CPIV/A-20/8, YCA18, CR86106) with validated immunogenicity. As a modified live vaccine, it stimulates rapid and robust immune responses, offering effective protection following proper immunization protocols.

After completion of the primary vaccination schedule, the vaccine provides up to 12 months of immunity, making it suitable for routine preventive programs in both companion animal clinics and commercial breeding operations.

Immunization Program

  • Puppies (Weaned Dogs):
    • 3 doses, 21-day intervals
    • 2.0 mL per dose (after reconstitution)
  • Adult Dogs:
    • 2 doses, 21-day interval
    • Revaccination recommended annually depending on risk exposure

Dosage & Administration

  • Route: Intramuscular injection
  • Dosage: 1 dose per vial, reconstituted to 2.0 mL with sterile diluent
  • Use immediately after reconstitution

Composition

Each dose contains:

  • Attenuated canine distemper virus (CDV/R-20/8): ≥ 10⁴.⁰ TCID50
  • Attenuated canine parainfluenza virus (CPIV/A-20/8): ≥ 10⁴.⁰ TCID50
  • Attenuated canine adenovirus (YCA18): ≥ 10⁴.⁰ TCID50
  • Attenuated canine parvovirus (CR86106): ≥ 10⁴.⁰ TCID50

Product Characteristics

  • Appearance: Slightly yellowish-white, spongy loose mass
  • Easily detaches from vial wall
  • After dilution: Clear pink liquid with rapid dissolution

Safety & Precautions

  • For preventive use only; not for treatment during active infection
  • Do not use in pregnant dogs
  • Dogs that received immune serum should wait 7–14 days before vaccination
  • Avoid stress factors such as transportation or environmental changes during vaccination period
  • Prevent contact with infected animals
  • In case of allergic reaction:
    • Administer epinephrine hydrochloride (0.5–1.0 mL IM) immediately
  • Use aseptic technique
  • Dispose of vaccine materials safely

Packaging & Specification

  • Specification: 1 dose/vial
  • Packaging: 20 vials/box

Storage & Shelf Life

  • Storage: 2–8°C
  • Protect from light
  • Shelf Life: 24 months

Contact us today to become a partner!

Inquire Now

Relate News

Get a free quote

Tell us what you need and we will get back to you within eight hours!

CONTACT US

Become our partner